Skip to main content
SpringerLink
Log in

Role of Chemotherapy in Ovarian Cancer

  • Chapter
Ovarian Carcinoma

  • 141 Accesses

Abstract

The pessimism and frustration that exist regarding the treatment of patients with ovarian cancer were well stated by Lewis and Blessing when they observed: “For ovarian cancer seemingly everything works, but practically nothing succeeds.” The despair and cynicism reflected in this statement seems justified when reports appear telling of improved therapeutic approaches but statistical mortality rates showing little trend toward improvement at 5 years. Carcinoma of the ovary remains the leading cause of death due to gynecologic cancer, and the results for 1991 were no better than for the previous two decades. New modalities of therapy are helping patients live longer and hopefully more comfortably, but the 5-year-survival rates have not improved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Bagley CM, Young RC, Canellos GP, et al: Treatment of ovarian carcinoma: possibilities for progress. N Engl J Med 287: 856, 1972.

    Article  PubMed  Google Scholar 

  • Barber HRK: Editorial Comment. In Barber HRK, Graber EA (eds): Surgical Disease in Pregnancy. Saunders, Philadelphia, 1974, p. 718.

    Google Scholar 

  • Barber HRK: Manual of Gynecologic Oncology. Lippincott, Philadelphia, 1980.

    Google Scholar 

  • Bruce WR: A model system for examining the action of anticancer agents at the cellular level in vivo. Natl Cancer Inst Monogr 24: 249, 1967.

    PubMed  CAS  Google Scholar 

  • Bruce WR, Meeker BE, Valenote FA: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37: 233, 1966.

    PubMed  CAS  Google Scholar 

  • Brulé G, Eckhardt SJ, Hall TC, Winkler A: Drug Therapy of Cancer. World Health Organization, Geneva, 1973.

    Google Scholar 

  • Carter SK, Bakowski MT, Hellmann K: Chemotherapy of Cancer. John Wiley & Sons, New York, 1977.

    Google Scholar 

  • Connors TA, Roberts JJ (eds): Platinum coordination complexes in cancer chemotherapy. In Recent Results in Cancer Research. Vol. 48. Springer-Verlag, Berlin, 1974.

    Google Scholar 

  • Dean JC, Salmon SE, Griffith KS: Prevention of doxorubicin-indueed hair loss with scalp hypothermia. N Engl J Med 301: 1427, 1979.

    Article  PubMed  CAS  Google Scholar 

  • De Vita VT, Schein PS: The use of drugs in combination for the treatment of cancer. N Engl J Med 288: 998, 1973.

    Article  Google Scholar 

  • Ehrlich CE, Einhorn L, Williams SD, Morgan J: Chemotherapy for stage II–IV epithelial ovarian cancer with ds-dichlorodiammine platinum II, Adriamycin, and cyclophosphamide: a preliminary report. Can Treat Rep 63: 281, 1979.

    CAS  Google Scholar 

  • Gove ME, Fryatt I, Wiltshaw E, et al: Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds. Gynecol Oncol 36: 207, 1990.

    Article  Google Scholar 

  • Hryniuk WM, Bertino JR: Rationale for selection of chemotherapeutic agents. Adv Intern Med 15: 267, 1969.

    PubMed  CAS  Google Scholar 

  • Kaufmann M: Clinical applications of in vitro chemosensitivity testing: ovarian cancer. Adv Biosci 26: 189, 1980.

    Google Scholar 

  • Klopp CT: Fractionated intraarterial cancer chemotherapy with methylbisamine hydrochloride, preliminary report. Ann Surg 132: 811, 1950.

    Article  PubMed  CAS  Google Scholar 

  • Lewis B, Young R: Adjuvant and first line chemotherapy for ovarian cancer: ovarian cancer Adv Biosci 26: 165, 1980.

    Google Scholar 

  • Lewis GC, Blessing J: Ovarian cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy. Cancer 40: 588, 1977.

    Article  PubMed  Google Scholar 

  • Manetta A, MacNeill C, Lyter J A, et al: Hexamethylmelamine as a single second live agent in ovarian cancer. Gynecol Oncol 36: 93, 1990.

    Article  PubMed  CAS  Google Scholar 

  • Parker RT, Parker CH, Wilbanks GD: Cancer of the ovary: survival studies based upon operative therapy, chemotherapy, and radiotherapy. Am J Obstet Gynecol 108: 878, 1970.

    PubMed  CAS  Google Scholar 

  • Pratt WB, Ruddon RW: The Anticancer Drugs. Oxford University Press, New York, 1979.

    Google Scholar 

  • Rosenberg B, Van Camp L, Kregas T: Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205: 698, 1965.

    Article  PubMed  CAS  Google Scholar 

  • Rowkinsky EK, Donehower RC, Jones RJ, et al: Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res 48: 4093, 1988.

    Google Scholar 

  • Salmon SE, Hamburger AW, Soehnlen B, et al: Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 298: 1321, 1978.

    Article  PubMed  CAS  Google Scholar 

  • Silver RT, Lauper RD, Jarowski CI: A Synopsis of Cancer Chemotherapy. Yorke Medical Group, New York, 1977.

    Google Scholar 

  • Skipper HE, Schabel FM, Wilcox WS: Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother Rep 35: 1, 1964.

    PubMed  CAS  Google Scholar 

  • Smith JP: Chemotherapy in advanced ovarian cancer. Natl Cancer Inst Monogr 42: 141, 1975.

    PubMed  CAS  Google Scholar 

  • Smith JP, Rutledge F, Wharton JT: Chemotherapy of ovarian cancer: new approaches to treatment. Cancer 30: 1565, 1972.

    Article  PubMed  CAS  Google Scholar 

  • Taxol Clinical Brochure, the Division of Cancer Treatment. National Cancer Institute, Bethesda, 1983.

    Google Scholar 

  • Thigpen TL, LaGasse L, Bundy B: Phase II trial of cis-platinum in treatment of advanced ovarian adenocarcinoma. Proc Am Assoc Cancer Res 20: 84, 1979.

    Google Scholar 

  • Van Eden EB, Falkson G, Van Dyk JJ, et al: 5-Fluorouracil, imidazole-4-carboxamide, vincristine and BCNu given concomitantly in the treatment of solid tumors in man. Cancer Chemother Rep 56 (1): 691, 1972.

    Google Scholar 

  • Wallace HJ, Higby DJ: Phase I evaluation of cis-platinum II diammine chloride (PDD) and a combination of PDD plus Adriamycin. In Recent Results in Cancer Research. Vol. 48. Springer-Verlag, Berlin, 1974, p. 167.

    Google Scholar 

  • Watkins E Jr, Sullivan RD: Cancer chemotherapy by prolonged arterial infusion. Surg Gynecol Obstet 118: 3, 1964.

    PubMed  Google Scholar 

  • Webb NJ, Malkasian GD, Jorgensen EO: Factors influencing ovarian cancer survival after chemotherapy. Obstet Gynecol 44: 564, 1974.

    Google Scholar 

  • Wiltshaw E, Kroner T: Phase II study of cis-dichloro-diammineplatinum (II) in advanced adenocarcinoma of the ovary. Cancer Treat Rep 60: 55, 1976.

    PubMed  CAS  Google Scholar 

  • Young RC: Chemotherapy of ovarian cancer: past and present. Semin Oncol 2: 267, 1975.

    PubMed  CAS  Google Scholar 

  • Young RC, Chabner BA, Hubbard ST, et al: Advanced ovarian adenocarcinoma: a perspective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 299: 1261, 1978.

    Article  PubMed  CAS  Google Scholar 

  • Young RC: Ovarian carcinoma: an optimistic epilogue. Can Treat Rep 63: 333, 1979.

    CAS  Google Scholar 

  • Young RC, Hubbard SP, DeVita VT: The chemotherapy of ovarian cancer. Cancer Treat Rep 1: 99, 1974.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Lenox Hill Hospital, 100 East 77th Street, 10021-1883, New York, NY, USA

    Hugh R. K. Barber M.D. (Director)

Authors
  1. Hugh R. K. Barber M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Barber, H.R.K. (1993). Role of Chemotherapy in Ovarian Cancer. In: Ovarian Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9232-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9232-3_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9234-7

  • Online ISBN: 978-1-4613-9232-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation